PDF(Pubmed)
Abstract：
UNASSIGNED: To describe the long-term effect of scleral buckling (SB) surgery for stage 4A retinopathy of prematurity (ROP).
UNASSIGNED: A retrospective chart review was conducted for patients with a diagnosis of stage 4A ROP who underwent SB between October 2010 and October 2021. Basic data were collected from patient charts, including gender, birth weight, gestational age at birth, disease stage, presence of plus disease, preoperative treatment [laser photocoagulation, intravitreal anti-vascular endothelial growth factor (VEGF) agent therapy, or a combination of both] and complications (vitreous hemorrhages), postmenstrual age at surgery, intraoperative combined treatment, and total length of follow-up. Retinal attachment status after surgery, postoperative complications (glaucoma, cataract), date and type of subsequent retinal surgeries (if performed), and refractive status 1 year after surgery were evaluated. The follow-up time after the first procedure was over 1 year.
UNASSIGNED: Six-two eyes from forty-eight patients met the inclusion criteria for this study. The initial reattachment rate was 93.5% (58/62 eyes), and the final reattachment rate was 100% after two procedures at the end of follow-up. The incidence of cataracts was 3.2% (2/62), with no eye subsequently needing lensectomy surgery. None of the patients developed glaucoma during the follow-up time. The average spherical equivalent refraction value for patients was -3.00 ± 2.51 D (-7.60 D to +2.75 D) 1 year after surgery.
UNASSIGNED: SB, especially segmental buckling, which induces less myopia and does not require buckle removal, has the potential to provide a significant positive impact in the treatment of stage 4A ROP.
UNASSIGNED: A retrospective chart review was conducted for patients with a diagnosis of stage 4A ROP who underwent SB between October 2010 and October 2021. Basic data were collected from patient charts, including gender, birth weight, gestational age at birth, disease stage, presence of plus disease, preoperative treatment [laser photocoagulation, intravitreal anti-vascular endothelial growth factor (VEGF) agent therapy, or a combination of both] and complications (vitreous hemorrhages), postmenstrual age at surgery, intraoperative combined treatment, and total length of follow-up. Retinal attachment status after surgery, postoperative complications (glaucoma, cataract), date and type of subsequent retinal surgeries (if performed), and refractive status 1 year after surgery were evaluated. The follow-up time after the first procedure was over 1 year.
UNASSIGNED: Six-two eyes from forty-eight patients met the inclusion criteria for this study. The initial reattachment rate was 93.5% (58/62 eyes), and the final reattachment rate was 100% after two procedures at the end of follow-up. The incidence of cataracts was 3.2% (2/62), with no eye subsequently needing lensectomy surgery. None of the patients developed glaucoma during the follow-up time. The average spherical equivalent refraction value for patients was -3.00 ± 2.51 D (-7.60 D to +2.75 D) 1 year after surgery.
UNASSIGNED: SB, especially segmental buckling, which induces less myopia and does not require buckle removal, has the potential to provide a significant positive impact in the treatment of stage 4A ROP.
摘要：
■描述巩膜屈曲（SB）手术治疗早产儿4A期视网膜病变（ROP）的长期效果。
■对2010年10月至2021年10月期间诊断为4A期ROP的患者进行回顾性图表回顾。基本数据来自患者图表，包括性别,出生体重,出生时的胎龄，疾病阶段,+疾病的存在，术前治疗[激光光凝，玻璃体内抗血管内皮生长因子(VEGF)药物治疗,或两者的组合]和并发症（玻璃体出血），手术后的月经年龄，术中联合治疗,和随访的总长度。术后视网膜附着状态,术后并发症（青光眼，白内障），后续视网膜手术的日期和类型（如果进行），术后1年评估屈光状态。第一次手术后的随访时间超过1年。
■48例患者的6-2只眼符合本研究的纳入标准。初次重贴率为93.5%(58/62眼),在随访结束时进行两次手术后，最终的再附着率为100％。白内障的发病率为3.2%(2/62),没有眼睛，随后需要进行晶状体切除术。在随访期间，没有患者出现青光眼。术后1年，患者的平均等效球面屈光度值为-3.00±2.51D（-7.60D至2.75D）。
■SB,尤其是节段屈曲，减少近视，不需要脱扣，有可能在4A期ROP的治疗中提供显著的积极影响。
■对2010年10月至2021年10月期间诊断为4A期ROP的患者进行回顾性图表回顾。基本数据来自患者图表，包括性别,出生体重,出生时的胎龄，疾病阶段,+疾病的存在，术前治疗[激光光凝，玻璃体内抗血管内皮生长因子(VEGF)药物治疗,或两者的组合]和并发症（玻璃体出血），手术后的月经年龄，术中联合治疗,和随访的总长度。术后视网膜附着状态,术后并发症（青光眼，白内障），后续视网膜手术的日期和类型（如果进行），术后1年评估屈光状态。第一次手术后的随访时间超过1年。
■48例患者的6-2只眼符合本研究的纳入标准。初次重贴率为93.5%(58/62眼),在随访结束时进行两次手术后，最终的再附着率为100％。白内障的发病率为3.2%(2/62),没有眼睛，随后需要进行晶状体切除术。在随访期间，没有患者出现青光眼。术后1年，患者的平均等效球面屈光度值为-3.00±2.51D（-7.60D至2.75D）。
■SB,尤其是节段屈曲，减少近视，不需要脱扣，有可能在4A期ROP的治疗中提供显著的积极影响。
